-
UNC receives more than $40 million from NIH for global clinical trials unit to treat and prevent HIV
-
The University of North Carolina at Chapel Hill has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.
Located in
News
/
2014
/
February
-
Drug helps purge hidden HIV virus, study shows
-
This study is the first to demonstrate that the biological mechanism that keeps the HIV virus hidden and unreachable by current antiviral therapies can be targeted and interrupted in humans, providing new hope for a strategy to eradicate HIV completely.
Located in
News
/
2012
/
March
-
International AIDS conference features UNC work
-
New results and next steps are the focus of the year’s most important HIV/AIDS research gathering. UNC researchers present findings on antiretroviral drugs, prevention approaches and community interventions.
Located in
Vital Signs
/
2010
/
Vital Signs - July 22, 2010
-
HIV/AIDS research and treatment timeline at UNC
-
The following timeline highlights events in HIV/AIDS research and treatment at the University of North Carolina and University of North Carolina Health Care System since 1981. Visit the link following each entry for more information.
Located in
Vital Signs
/
2011
/
June 2
-
Registration now open for UNC HIV Care 2009: Antiretroviral Therapy, Hepatitis B/C, Addiction, and Adherence
-
The purpose of this conference is to provide an update on treatment of Hepatitis B and C, drug addiction and adherence.
Located in
Vital Signs
/
2009
/
March
-
Cohen named "Tar Heel of the Year" by the Raleigh News & Observer
-
Myron Cohen, MD, J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Epidemiology, was featured in the Sunday, Dec. 30 issue of the N&O along with Robert J. Lefkowitz, MD, also a "Tar Heel of Year" for 2012.
Located in
News
/
2012
/
December
-
New findings from University of North Carolina-led HIV prevention study, HPTN 052
-
UNC researchers presented detailed data from the landmark HIV Prevention Trials Network (HPTN) 052 study today at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.
Located in
News
/
2011
/
July
-
UNC faculty, trainees presented in record numbers at CROI 2011
-
The 18th Annual Conference on Retroviruses and Opportunistic Infections (CROI) wrapped up in Boston, Massachusetts, earlier this month, and UNC had a strong presence at this year’s conference.
Located in
Vital Signs
/
2011
/
March 17
-
Innate immune system can kill HIV when a viral gene is deactivated
-
Study published in PLoS Pathogens suggests new target for treatment and the eventual cure of HIV/AIDS
Located in
News
/
2013
/
March
-
UNC to partner in new global HIV/AIDS project
-
Supporting Operational AIDS Research (SOAR) is a global research project to determine how best to address challenges and gaps that remain in the delivery of HIV and AIDS care and support, treatment, and prevention services.
Located in
Vital Signs
/
2014
/
Oct. 2